Vestipitant

Vestipitant
Systematic (IUPAC) name
	(2S)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide
Identifiers
CAS Number	334476-64-1
ATC code	none
PubChem	CID: 9832383
IUPHAR/BPS	5757
ChemSpider	8008111
UNII	S052TOI9BI
ChEMBL	CHEMBL522987
Chemical data
Formula	C23H21F10N3O
Molecular mass	545.416 g/mol
	SMILES FC(F)(F)c1cc(F)ccc1C2CNCCN2C(=O)N(C)C(C)c3cc(C(F)(F)F)cc(c3)C(F)(F)F ;
	InChI InChI=1S/C23H24F7N3O/c1-13-8-18(24)4-5-19(13)20-12-31-6-7-33(20)21(34)32(3)14(2)15-9-16(22(25,26)27)11-17(10-15)23(28,29)30/h4-5,8-11,14,20,31H,6-7,12H2,1-3H3/t14-,20-/m1/s1 ; Key:SBBYBXSFWOLDDG-JLTOFOAXSA-N ;
(what is this?) (verify)

Vestipitant is a drug developed by GlaxoSmithKline which acts as a selective antagonist for the NK₁ receptor. It is under development as a potential antiemetic and anxiolytic drug,^[1]^[2] and as a treatment for tinnitus^[3] and insomnia.^[4]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

↑ Lua error in package.lua at line 80: module 'strict' not found.
↑ Lua error in package.lua at line 80: module 'strict' not found.
↑ Clinical trial number NCT00394056 for "Vestipitant Or Vestipitant/Paroxetine Combination In Subjects With Tinnitus And Hearing Loss" at ClinicalTrials.gov
↑ Lua error in package.lua at line 80: module 'strict' not found.